Your browser doesn't support javascript.
loading
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.
Mato, Anthony R; Roeker, Lindsey E; Jacobs, Ryan; Hill, Brian T; Lamanna, Nicole; Brander, Danielle; Shadman, Mazyar; Ujjani, Chaitra S; Yazdy, Maryam Sarraf; Perini, Guilherme Fleury; Pinilla-Ibarz, Javier A; Barrientos, Jacqueline; Skarbnik, Alan P; Torka, Pallawi; Pu, Jeffrey J; Pagel, John M; Gohil, Satyen; Fakhri, Bita; Choi, Michael; Coombs, Catherine C; Rhodes, Joanna; Barr, Paul M; Portell, Craig A; Parry, Helen; Garcia, Christine A; Whitaker, Kate J; Winter, Allison M; Sitlinger, Andrea; Khajavian, Sirin; Grajales-Cruz, Ariel F; Isaac, Krista M; Shah, Pratik; Akhtar, Othman S; Pocock, Rachael; Lam, Kentson; Voorhees, Timothy J; Schuster, Stephen J; Rodgers, Thomas D; Fox, Christopher P; Martinez-Calle, Nicolas; Munir, Talha; Bhavsar, Erica B; Bailey, Neil; Lee, Jason C; Weissbrot, Hanna B; Nabhan, Chadi; Goodfriend, Julie M; King, Amber C; Zelenetz, Andrew D; Dorsey, Colleen.
Afiliación
  • Mato AR; Memorial Sloan Kettering Cancer Center, New York, New York. matoa@mskcc.org.
  • Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jacobs R; Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, North Carolina.
  • Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Lamanna N; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York.
  • Brander D; Duke University Medical Center, Durham, North Carolina.
  • Shadman M; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Ujjani CS; Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Yazdy MS; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington D.C.
  • Perini GF; Hospital Israelita Albert Einstein, Sao Paulo, Pará, Brazil.
  • Pinilla-Ibarz JA; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida.
  • Barrientos J; North Shore University Hospital, Northwell Health, Manhasset, New York.
  • Skarbnik AP; Novant Health, Charlotte, North Carolina.
  • Torka P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Pu JJ; SUNY Upstate Medical University, Syracuse, New York.
  • Pagel JM; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington.
  • Gohil S; University College London, London, United Kingdom.
  • Fakhri B; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.
  • Choi M; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Coombs CC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
  • Rhodes J; Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Barr PM; Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, New York.
  • Portell CA; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia.
  • Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Garcia CA; Hillman Cancer Pavilion, Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Whitaker KJ; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Winter AM; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Sitlinger A; Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Khajavian S; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Grajales-Cruz AF; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida.
  • Isaac KM; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia.
  • Shah P; Northwell Health, New York, New York.
  • Akhtar OS; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Pocock R; University of College of London, London, United Kingdom.
  • Lam K; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Voorhees TJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
  • Schuster SJ; Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Rodgers TD; University of Rochester Medical Center, Rochester, New York.
  • Fox CP; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Martinez-Calle N; Clinical Haematology Department, Nottingham University Hospitals NHS Trust, Nottingham, England, United Kingdom.
  • Munir T; Weill Cornell Medicine, Long Island City, New York.
  • Bhavsar EB; Department of Haematology, St James's University Hospital, Leeds, United Kingdom.
  • Bailey N; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington.
  • Lee JC; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York.
  • Weissbrot HB; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York.
  • Nabhan C; Aptitude Health, Atlanta, Georgia.
  • Goodfriend JM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • King AC; Clinical Pharmacy Specialist-Leukemia, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zelenetz AD; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dorsey C; Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Cancer Res ; 26(14): 3589-3596, 2020 07 15.
Article en En | MEDLINE | ID: mdl-32198151
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article